Young outstanding researchers of this disease are awarded the Georg Rajka medal. Recent clinical trials for this disease include the Nemluvio trials ARCADIA 1 and 2, and LIBERTY AD CHRONOS. It’s not breathing-related, but this is the most common disease treated by an injected medication that binds IL-4 receptor (15[1])alpha to inhibit interleukin 4 and 13 signaling. (-5[1])The monoclonal antibody medication dupilumab, or Dupixent, (-5[1])most commonly treats this disease, (15[1]-5[1])which causes (-5[1])pruritus on the (*) hands and neck, behind the knees, and in the creases of elbows. Types of this disease include nummular, (-5[1])seborrhoeic, (10[1])and a “contact” form caused (10[1])by a specific trigger of IgE (“eye-G-E”). This disease, asthma, and hay fever comprise the atopic triad. (10[1])For 10 points, name this disease in which chronic inflammation yields (-5[1])red and itchy (10[1])skin. ■END■ (10[5])